Katarina Komatović

4-Aminoquinoline-Based Adamantanes as Potential Anticholinesterase Agents in Symptomatic Treatment of Alzheimer’s Disease

M. Zlatović, Sandra Šegan, D. Opsenica, 2022, Pharmaceutics.